β-catenin, cartilage, and osteoarthritis

Annals of the New York Academy of Sciences

Volumn 1192, Issue , 2010, Pages 344-350

  Wu, Qiuqian ^a   Zhu, Mei ^a   Rosier, Randy N ^a   Zuscik, Michael J ^a   O'Keefe, Regis J ^a   Chen, Di ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Articular chondrocyte; Conditional activation; Osteoarthritis; catenin

Indexed keywords

ARGININE; BETA CATENIN; BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN FIBRIL; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 9; COLLAGENASE 3; ESTROGEN RECEPTOR; HYBRID PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; PROSTAGLANDIN; PROTEOGLYCAN; SMAD3 PROTEIN; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

AGE; ALLELE; BONE MATURATION; BONE MINERALIZATION; CARTILAGE; CARTILAGE CELL; CELL CLONING; CELL FUNCTION; CONFERENCE PAPER; DISEASE COURSE; EPIPHYSIS; EXTRACELLULAR MATRIX; GENE EXPRESSION; GROWTH PLATE; HAPLOTYPE; HEART; HIP; IN VIVO STUDY; JOINT CAVITY; KIDNEY; KNEE; LIVER; LONG BONE; LUNG; OBESITY; OSSIFICATION; OSTEOARTHRITIS; OSTEOPHYTE; PHOSPHORYLATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN; SPINE; SPLEEN; TENSILE STRENGTH; TIBIA; TRACHEA; UPREGULATION;

EID: 77950664529     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05212.x     Document Type: Conference Paper

References (53)

1. Kronenberg, H.M. 2003. Developmental regulation of the growth plate [review]. Nature 423: 332-336.
2. Kulyk,W.M., B.J. Rodgers, K. Greer, et al. 1989. Promotion of embryonic chick limb cartilage differentiation by transforming growth factor-beta. Dev. Biol. 135: 423-430.
3. Serra, R., M. Jonson, E.H. Filvaroff, et al. 1997. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J. Cell. Biol. 139: 541-552.
4. Yang, X., L. Chen, X. Xu, et al. 2001. TGF-β/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell. Biol. 153: 35-46.
5. Yoon, B.S., D.A. Ovchinnikov, I. Yoshii, et al. 2005. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc.Natl. Acad. Sci. USA 102: 5062-5067.
6. Day, T.F., X. Guo, L. Garrett-Beal, et al. 2005. Wnt/betacatenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell. 8: 739-750.
7. Chen, M., M. Zhu, H. Awad, et al. 2008. Inhibition ofβ-catenin signaling causes defects in postnatal cartilage development. J. Cell Sci. 121(Pt 9): 1455-1465.
8. M. Oka, S. Kubota, S. Kondo, et al. 2007. Gene expression and distribution of connective tissue growth factor (CCN2/CTGF) during secondary ossification center formation. J. Histochem. Cytochem. 55: 1245-1255.
9. K.M. Kwan, M.K. Pang, S. Zhou, et al. 1997. Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function. J. Cell. Biol. 136: 459-471. (Pubitemid 27063094)
10. Jacenko,O.,D.Chan, A. Franklin, et al. 2001.Adominant interference collagen X mutation disrupts hypertrophic chondrocyte pericellular matrix and glycosaminoglycan and proteoglycan distribution in transgenic mice. Am. J. Pathol. 159: 2257-2269. (Pubitemid 33104279)
11. Kim, H.J.& T. Kirsch. 2008. Collagen/annexin V interactions regulate chondrocyte mineralization. J. Biol. Chem. 283: 10310-10317.
12. Kannu, P., J.F. Bateman, D. Belluoccio, et al. 2009. Employing molecular genetics of chondrodysplasias to inform the study of osteoarthritis. Arthritis Rheum. 60: 325-334.
13. Verzijl, N., J. DeGroot, S.R. Thorpe, et al. 2000. Effect of collagen turnover on the accumulation of advanced glycation end products. J. Biol. Chem. 275: 39027-39031. (Pubitemid 32058915)
14. Pacifici, M., E. Koyama, M. Iwamoto, 2005.Mechanisms of synovial joint and articular cartilage formation: recent advances, butmany lingeringmysteries. BirthDefectsRes. C Embryo Today 75: 237-248. (Pubitemid 41456325)
15. von derMark, K., T.Kirsch, A. Nerlich, et al. 1992. Type X collagen synthesis in human osteoarthritic cartilage: indication of chondrocyte hypertrophy.ArthritisRheum. 35: 806-811.
16. Zhu, M., D. Tang, Q. Wu, et al. 2009. Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J. Bone Miner. Res. 24: 12-21.
17. Wu, Q., K.O. Kim, E.R. Sampson, et al. 2008. Smurf2 induces an osteoarthritis-like phenotype and degrades phosphorylated Smad3 in transgenic mice. Arthritis Rheum. 58: 3132-3144.
18. Song, R.H., M.D. Tortorella, A.M. Malfait, et al. 2007. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum. 56: 575-585. (Pubitemid 46271983)
19. Woolf, A.D. & B. Pfleger, 2003. Burden of major musculoskeletal conditions. Bull. World Health Organ. 81: 646-656. (Pubitemid 37254686)
20. Lawrence, R.C., D.T. Felson, C.G. Helmick, et al. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in theUnited States: Part II. Arthritis Rheum. 58: 26-35.
21. Li, Y., L. Xu & B.R. Olsen, 2007. Lessons from genetic forms of osteoarthritis for the pathogenesis of the disease. Osteoarthritis Cartilage 15: 1101-1105. (Pubitemid 47387056)
22. Helminen, H.J., A.M. Saamanen, H. Salminen, et al. 2002. Transgenic mouse models for studying the role of cartilage macromolecules in osteoarthritis. Rheumatology (Oxford) 41: 848-856.
23. Neuhold, L.A., L. Killar, W. Zhao, et al. 2001. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Invest. 107: 35-44. (Pubitemid 32047412)
24. Kawaguchi, H. 2009. Regulation of osteoarthritis development by Wnt-beta-catenin signaling through the endochondral ossification process. J. Bone Miner. Res. 24: 8-11.
25. van Beuningen, H.M., H.L. Glansbeek, P.M. van der Kraan, et al. 2000. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 8: 25-33.
26. Bakker, A.C., F.A.J. van de Loo, H.M. van Beuningen, et al. 2000. Overexpression of active TGF-b-1 in the murine knee joint: evidence for synovial-layerdependent chondrosteophyte formation. Osteoarthritis Cartilage 9: 128.
27. Davidson, E.N.B., E.L. Vitters, H.M. van Beumingen, et al. 2007. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum. 56: 4065-4073.
28. Loughlin, J. 2002. Genome studies and linkage in primary osteoarthritis [review]. Rheum. Dis. Clin. North Am. 28: 95-109. (Pubitemid 34111679)
29. Spector, T.D. & A.J. MacGregor. 2004. Risk factors for osteoarthritis: genetics [review]. Osteoarthritis Cartilage 12(Suppl A): S39-44. (Pubitemid 38950276)
30. Slagboom, P.E., B.T. Heijmans, M. Beekman, et al. 2000. Genetics of human aging: the search for genes contributing to human longevity and diseases of the old [review]. Ann. N. Y. Acad. Sci. 908: 50-63. (Pubitemid 30461992)
31. Loughlin, J., Z. Mustafa, A. Smith, et al. 2000. Linkage analysis of chromosome 2q in osteoarthritis. Rheumatology (Oxford) 39: 377-381. (Pubitemid 30307322)
32. Loughlin, J., B. Dowling, K. Chapman, et al. 2004. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc. Natl. Acad. Sci. USA 101: 9757-9762. (Pubitemid 38869309)
33. Min, J.L., I. Meulenbelt, N. Riyazi, et al. 2005. Association of the Frizzled-related protein gene with symptomatic osteoarthritis at multiple sites. Arthritis Rheum. 52: 1077-1080. (Pubitemid 40530114)
34. Lane, N.E., K. Lian, M.C. Nevitt, et al. 2006. Frizzledrelated protein variants are risk factors for hip osteoarthritis. Arthritis Rheum. 54: 1246-1254. (Pubitemid 43672936)
35. Enomoto-Iwamoto, M., J. Kitagaki, E. Koyama, et al. 2002. The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis. Dev. Biol. 251: 142-156. (Pubitemid 35333753)
36. Tamamura, Y., T. Otani, N. Kanatani, et al. 2005. Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J. Biol. Chem. 280: 19185-19195. (Pubitemid 41379625)
37. Lories, R.J., J. Peeters, A. Bakker, et al. 2007. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum. 56: 4095-4103. (Pubitemid 350262337)
38. Blom, A.B., S.M. Brockbank, P.L. van Lent, et al. 2009. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum. 60: 501-512.
39. Loughlin, J. 2005. Polymorphism in signal transduction is a major route through which osteoarthritis susceptibility is acting [review]. Curr. Opin. Rheumatol. 17: 629-633. (Pubitemid 41527826)
40. Weir, E.C., W.M. Philbrick, M. Amling, et al. 1996. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc. Natl. Acad. Sci. USA 93: 10240-10245. (Pubitemid 26314606)
41. Schipani, E., B. Lanske, J. Hunzelman, et al. 1997. Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc. Natl. Acad. Sci. USA 94: 13689-13694.
42. Takeda, S., J.P. Bonnamy, M.J. Owen, et al. 2001. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1- deficient mice. Genes Dev. 15: 467-481. (Pubitemid 32187007)
43. Stricker, S., R. Fundele, A. Vortkamp, et al. 2002. Role of Runx genes in chondrocyte differentiation. Dev. Biol. 245: 95-108.
44. Indra,A.K., X.Warot, J. Brocard, et al. 1999. Temporallycontrolled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res. 27: 4324-4327.
45. Metzger,D., M. Li&P.Chambon, 2005.Targeted somatic mutagenesis in the mouse epidermis. MethodsMol. Biol. 289: 329-340.
46. Reed, C.A., A.K. Berndtson & K.P. Nephew, 2005. Dosedependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus. Anticancer Drugs 16: 559-567.
47. Chen, M., A.C. Lichtler, T. Sheu, et al. 2007 Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression ofCre recombinase. Genesis 45: 44-50.
48. Zhu, M.,M. Chen, A.C. Lichtler, et al. 2008. Tamoxifeninducible Cre-recombination in articular chondrocytes of adult Col2a1-CreERT2 transgenic mice. Osteoarthr. Cartilage 16: 129-130.
49. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21: 70-71.
50. Mao, X., Y. Fujiwara & S.H. Orkin, 1999. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc. Natl. Acad. Sci. USA 96: 5037-5042.
51. Harada, N., Y. Tamai, T. Ishikawa, et al. 1999. Intestinal polyposis in mice with a dominant stable mutation of theβ-catenin gene. EMBO J. 18: 5931-5942.
52. Wu,Q.,D.Chen,M.J. Zuscik, et al. 2008. Overexpression of Smurf2 stimulates endochondral ossification through up-regulation of beta-catenin. J. Bone Miner. Res. 23: 552-563.
53. Wu, Q., J.H. Huang, E.R. Sampson, et al. 2009. Smurf2 induces degradation of GSK-3beta and upregulates betacatenin in chondrocytes: A potential mechanism for Smurf2-induced degeneration of articular cartilage. Exp. Cell. Res. 315: 2386-2398.